Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Current Taxes for 3 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Taxes rose 56.15% year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Dec 2025, up 56.15%, and an annual FY2025 reading of $1.4 million, up 56.15% over the prior year.
  • Current Taxes was $1.4 million for Q4 2025 at Catalyst Pharmaceuticals, up from $710000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $11.1 million in Q1 2025 and bottomed at $15000.0 in Q2 2024.
  • Average Current Taxes over 3 years is $2.2 million, with a median of $729000.0 recorded in 2023.
  • The sharpest move saw Current Taxes increased 22.63% in 2024, then soared 2826.67% in 2025.
  • Year by year, Current Taxes stood at $729000.0 in 2023, then rose by 22.63% to $894000.0 in 2024, then surged by 56.15% to $1.4 million in 2025.
  • Business Quant data shows Current Taxes for CPRX at $1.4 million in Q4 2025, $710000.0 in Q3 2025, and $439000.0 in Q2 2025.